Fresh Equities
Raises
Research
About
Looking for more information?

Contact our responsive and friendly client services team any time.

POLYNOVO LIMITED

INVESTOR PRESENTATION - POLYNOVO LIMITED

ASX:PNV

POLYNOVO LIMITED

Health Care

Polynovo Limited (PNV, formerly Calzada Limited) is an Australian based medical device company that designs, develops and manufactures dermal regeneration solutions using its patented NovoSorb biodegradable polymer technology. Their development program covers Breast Sling, Hernia, and Orthopedic applications. Former Names Metabolic Pharmaceuticals Limited (MBP) on 30/11/2009; Calzada Limited (CZD), 28/11/2014

Read more

Market Cap

1.46b

Price at Close

$2.21

4w avg. Volume

2.58m

4w avg. Turnover

$5.71m

Announcements
announcementt+2 movementdate
  • Appointment of distributor for Finland

    Progress Report · Market sensitive

  • 0.00%

    22 Sep 2020

0.00%

22 Sep 2020
  • FDA feedback on Pivotal Protocol

    Progress Report

  • +2.34%

    10 Sep 2020

+2.34%

10 Sep 2020
  • Victorian Government Grant for Hernia Plant

    Periodic Reports

  • 0.00%

    06 Sep 2020

0.00%

06 Sep 2020
  • Director Share Purchase - David Williams

    Shareholder Details

  • +9.41%

    27 Aug 2020

+9.41%

27 Aug 2020
  • Corporate Governance Statement

    Periodic Reports

  • +5.56%

    26 Aug 2020

+5.56%

26 Aug 2020
  • Appendix 4G

    Periodic Reports

  • +5.56%

    26 Aug 2020

+5.56%

26 Aug 2020
  • FY20 Results Presentation

    Periodic Reports · Market sensitive

  • +5.56%

    26 Aug 2020

+5.56%

26 Aug 2020
  • Appendix 4E and FY20 Annual Report

    Periodic Reports · Market sensitive

  • +5.56%

    26 Aug 2020

+5.56%

26 Aug 2020
  • FY20 Results Webcast

    Company Administration

  • -8.09%

    23 Aug 2020

-8.09%

23 Aug 2020
  • BARDA funding for Pivotal Trial

    Progress Report · Market sensitive

  • -1.74%

    14 Jul 2020

-1.74%

14 Jul 2020
Market Data

Current Price

$2.21

52WK HIGH

$3.285

52WK LOW

$1.275

1YR RETURN

-0.45%

1YR RETURN VS. SECTOR

-28.73%

90 DAY RETURN

-17.84%

ASX RANK

194

/2,016

SECTOR RANK

3

/47

SHARES OUTSTANDING

661.09m
ASX:PNV

POLYNOVO LIMITED

Health Care

Polynovo Limited (PNV, formerly Calzada Limited) is an Australian based medical device company that designs, develops and manufactures dermal regeneration solutions using its patented NovoSorb biodegradable polymer technology. Their development program covers Breast Sling, Hernia, and Orthopedic applications. Former Names Metabolic Pharmaceuticals Limited (MBP) on 30/11/2009; Calzada Limited (CZD), 28/11/2014

Read more

Market Cap

1.46b

Price at Close

$2.21

4w avg. Volume

2.58m

4w avg. Turnover

$5.71m

ASX:PNV is not raising right now

Want to invest?

Fresh Equities

Copyright © 2020 Fresh Equities. All rights reserved. ACN 619 657 028. CAR: 001267539 of AFSL: 471379.

Contact Us

(03) 9028 2888

clients@freshequities.com

Address

Level 7, 388 Bourke St
Melbourne VIC 3000
Australia

Copyright © 2020 Fresh Equities. All rights reserved. ACN 619 657 028. CAR: 001267539 of AFSL: 471379.